Effect of Yoga in addition to Pharmacotherapy on Symptomatic Depression and Quality of Life in Patients of Diabetic Neuropathy: A Pilot Study

Neuropathy is a common diabetes complication that can't be treated. Diabetes mellitus causes insulin resistance or decreased insulin production. India is considered as the "diabetes world capital," with 98 million patients expected by 2030. 150 million people worldwide have diabetes mellitus, and this number could double by 2025. Aim of this study: To see effect of 1 month of Yoga module practice on depression and quality of life in patients of Diabetic Neuropathy. Materials and Methods: This study used n=10 type 2 diabetes mellitus patients from AIIMS Rishikesh's OPD. This study aims to determine the effect of 30 days of Yoga asanas on diabetic neuropathy patients' depression and quality of life. WHO-5 well-being index was used to measure life quality. 0-10 years of diabetes. DAN patient. Participants were asked to do daily yoga online with a yoga pro using Zoom. 30-45 minutes of yoga 6 days a week for 1 month. Subjects were given medications and food. After 30 days of Yogic practice, the PHQ-9 and WHO-5 Well-being index scores were repeated. Results: Total 10 patients were included for this pilot study, mean age 59.4 and average BMI was 26.76 We found that yoga practice is beneficial for diabetic neuropathy patients in managing the symptoms of depression (p< 0.005) and improving quality of life (p< .005) Conclusion: Yoga is a recognized non pharmacotherapy. Yoga in addition to Pharmacotherapy is to be beneficial in managing symptoms of depression and to improving Quality of Life of Diabetic neuropathy patients.